BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 11900279)

  • 1. D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance.
    Larner J
    Int J Exp Diabetes Res; 2002; 3(1):47-60. PubMed ID: 11900279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.
    Asplin I; Galasko G; Larner J
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5924-8. PubMed ID: 8392181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.
    Sun TH; Heimark DB; Nguygen T; Nadler JL; Larner J
    Biochem Biophys Res Commun; 2002 May; 293(3):1092-8. PubMed ID: 12051772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.
    Kennington AS; Hill CR; Craig J; Bogardus C; Raz I; Ortmeyer HK; Hansen BC; Romero G; Larner J
    N Engl J Med; 1990 Aug; 323(6):373-8. PubMed ID: 2370888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Lilley K; Larner J; Hansen BC
    Endocrinology; 1993 Feb; 132(2):640-5. PubMed ID: 8425483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat.
    Kawa JM; Przybylski R; Taylor CG
    Exp Biol Med (Maywood); 2003 Sep; 228(8):907-14. PubMed ID: 12968062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy.
    Larner J; Allan G; Kessler C; Reamer P; Gunn R; Huang LC
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):127-37. PubMed ID: 10212830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.
    Campbell WW; Ostlund RE; Joseph LJ; Farrell PA; Evans WJ
    Horm Metab Res; 2001 Jan; 33(1):44-51. PubMed ID: 11280715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-chiro-inositol metabolism in diabetes mellitus.
    Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity.
    Larner J; Price JD; Heimark D; Smith L; Rule G; Piccariello T; Fonteles MC; Pontes C; Vale D; Huang L
    J Med Chem; 2003 Jul; 46(15):3283-91. PubMed ID: 12852758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys.
    Ortmeyer HK; Huang LC; Zhang L; Hansen BC; Larner J
    Endocrinology; 1993 Feb; 132(2):646-51. PubMed ID: 8425484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.
    Farese RV; Standaert ML; Yamada K; Huang LC; Zhang C; Cooper DR; Wang Z; Yang Y; Suzuki S; Toyota T
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11040-4. PubMed ID: 7972005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.
    Jung TS; Hahm JR; Kim JJ; Jung JH; Kang MY; Moon SW; Lee KW; Kim HC; Lee JD; Kim JH; Kim DR; Chung SI
    Yonsei Med J; 2005 Aug; 46(4):532-8. PubMed ID: 16127779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of skeletal muscle glucose 6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-dependent diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Hansen BC
    Diabetologia; 1994 Feb; 37(2):127-33. PubMed ID: 8163045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.
    Huang LC; Fonteles MC; Houston DB; Zhang C; Larner J
    Endocrinology; 1993 Feb; 132(2):652-7. PubMed ID: 8425485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action.
    Brautigan DL; Brown M; Grindrod S; Chinigo G; Kruszewski A; Lukasik SM; Bushweller JH; Horal M; Keller S; Tamura S; Heimark DB; Price J; Larner AN; Larner J
    Biochemistry; 2005 Aug; 44(33):11067-73. PubMed ID: 16101290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes.
    Suzuki S; Kawasaki H; Satoh Y; Ohtomo M; Hirai M; Hirai A; Hirai S; Onoda M; Matsumoto M; Hinokio Y
    Diabetes Care; 1994 Dec; 17(12):1465-8. PubMed ID: 7882818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls.
    Heimark D; McAllister J; Larner J
    Endocr J; 2014; 61(2):111-7. PubMed ID: 24189751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients.
    Yki-Järvinen H; Sahlin K; Ren JM; Koivisto VA
    Diabetes; 1990 Feb; 39(2):157-67. PubMed ID: 2121571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.